We have had two pieces of good news about health research of patient benefit this week. First, the National Institute for Health and Care Excellence (NICE) issued new guidance saying that tamoxifen or raloxifene taken daily for five years can cut breast cancer risk by 40%. This means women at risk of developing breast cancer have… Read More Blog: We have the public to thank for this week’s well-informed decisions in health research
I am indebted to a good friend and colleague of mine who, some time ago, sent me this BBC News story from last year. It reports on the rising concerns among Himalayan Sherpas about the lack of regard being shown towards their needs and the environment as scientists tromp all over the local geography. To the… Read More Comment: The Sherpa’s story and its relevance to public involvement in health research
All hail today’s Dilnot Commission report. If ever there was a shining – or should I say less than shining – example of the way in which Government has failed its population it is long-term care. This failure has manifested itself in the difficulties faced by many people in accessing and paying for good quality… Read More Dilnot presents us all with a second opportunity on long-term care
Here’s the BBC report on how the Health and Social Care Bill will now be scrutinised following the changes announced a few weeks ago. I think other reports have mentioned people’s criticisms of it going back to the committee stage for only ten days in all.
The Science Minister, David Willetts MP, has been speaking today at University UK’s Spring Conference (have UUK actually seen the weather out there?). The full text of his speech is available from the Department for Business, Innovation and Skills website but I was very pleased to see this section in it: ‘There’s another issue too. We are… Read More Willetts at UUK Spring Conference – white paper, postgraduate education etc